SAN ANTONIO--(BUSINESS WIRE)--OncoVista Innovative Therapies, Inc. (OTCBB:OVIT), a biopharmaceutical company engaged in the development and commercialization of targeted cancer therapies, announced today that its company information will be made available via Standard & Poor’s Market Access Program, an information distribution service that enables subscribing publicly traded companies to have their company information disseminated to users of Standard & Poor’s Advisor Insight. The company information to be made available through this program includes share price, volume, dividends, shares outstanding, company financial position, and earnings. Standard & Poor’s Advisor Insight is an Internet-based research engine used by more than 100,000 investment advisors. A public version of the site is available at www.advisorinsight.com.
